Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic acyclovir 200 mg vs Zovirax in healthy Thai volunteers under fasting
TCTR20200807002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aciclovir in herpes simplex (HSV) (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic parameters. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on TCTR20200807002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200807002.